IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sofinnova Investments, Inc.

Q1 2022 Holdings

Filed 2022-05-16 | 64 holdings | $84.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Invesco QQQ Trust Series 1(QQQ)PutCOMM46090E103$63.4K175,0000.1%
Aerovate Therapeutics, Inc.COMM008064107$68.9K3,758,6860.1%
Vera Therapeutics, Inc.(VERA)CL A92337R101$74.7K3,181,4420.1%
Cincor Pharma, Inc.COMM17240Y109$97.8K5,573,9490.1%
Natera Inc(NTRA)COMM632307104$126.2K3,102,9600.1%
Karuna Therapeutics IncCOMM48576A100$247.6K1,953,0770.3%
Amylyx Pharmaceuticals Inc(AMLX)COMM03237H101$1.3M100,0001.5%
Cytokinetics Inc(CYTK)COMM23282W605$2.3M62,9442.7%
Bicycle Therapeutics PLC(BCYC)ADR088786108$7.2M163,5598.5%
Biomarin Pharmaceutical Inc(BMRN)COMM09061G101$13.6M176,53316.1%
Ascendis Pharma A/S(ASND)ADR04351P101$58.7M499,82469.6%
PreviousPage 2 of 2